Universities In Australia 
Universities In Canada 
Universities In Germany 
Universities In Ireland 
Universities In Jordan 
Universities In New Zealand 
Universities In Saudi Arabia 
Universities In United Kingdom 
Universities In United States Of America 
About this degree
This one-year, full-time programme will provide you with the latest advances in the rapidly growing sector of advanced therapies and regenerative medicine, as well as providing an in-depth industry perspective, research experience with internationally renowned research groups and key transferable skills to catapult your career.
Through close industry partner involvement in the development and delivery of this programme, you will be introduced to real-life case studies of novel therapeutic manufacture. In addition to being taught by UCL academics who will draw upon extensive industrial research collaborations, you will receive lectures from industry experts and guest speakers to provide you with the industrial relevance and the wider commercial context. You will, therefore, benefit greatly from the academic expertise and real-world commercial and clinical insights which will be brought together through this holistic educational approach.
Students will learn the manufacturing and commercial requirements for advanced therapies via lectures, company site visits and extensive practical laboratory training. Leading industry professionals will teach the commercial and regulatory requirements.
Students will:
- Understand requirements for translation from bench to bedside.
- Learn from venture capitalists/life science business professionals.
- Learn transferable management/communication skills.
- Receive support/mentoring to make informed career choices
Who this course is for
This MSc will enable and empower two types of complementary future leaders:
(1) Scientific and Manufacturing Leaders: those who further and lead scientific R&D/manufacturing activity within the sector.
(2) Business and Technology Leaders: those who understand the key business/technology innovations and drive commercial growth, profitability and operational excellence to maintain competitive advantage.
What this course will give you
This innovative and unique programme will involve a combination of both biological and lab-based bioprocessing studies in conjunction with core research-based educational content covering a range of novel therapeutic modalities and the translation of these advanced therapies from the laboratory to the market.
On our MSc, you will develop the key skills required for the stages of the translational pathway of stem cell and gene therapy products, including fundamental biology, viral/non-vector design, pre-clinical and clinical studies, GMP manufacturing, technology innovation, process analytical technologies, risk-based analysis (e.g. Quality by Design), quality assurance and control, clinical design, commercialisation and market authorisation.
The MSc places special emphasis on exposing you to a wide range of industrially-enriching experiences including visits to manufacturing sites to embed learning and enable you to develop your professional network.
You will therefore benefit greatly from the academic expertise and real-world commercial insights brought together through this holistic educational approach.
The practical and hands-on nature of the course means that you will learn key laboratory techniques and research skills including aseptic cell culture training, the growth, maintenance and characterization of different types of stem cells (embryonic and adult stem cell) and other key cell types of interest (e.g. T-cells).
The programme is hosted by the Department of Biochemical Engineering which is the leading UK centre for biochemical and bioprocess engineering and has been awarded over £100M in research and infrastructure funding to addressing the bioprocessing challenges of biologics, vaccines and advanced therapies.
In 2023, the programme will transfer to the UCL East campus on the Queen Elizabeth Olympic Park which provides an exciting opportunity for enhancing delivery of the department’s educational programmes.